Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a correction. Please see:

Correction: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells - September 01, 2022

PDF +
Supplementary
Material

Immune cell therapies and immune cell engineering

Original research

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

Online download statistics by month:

Online download statistics by month: August 2022 to March 2024

	Abstract	Full	Pdf
Aug 2022	815	846	231
Sep 2022	336	354	119
Oct 2022	221	230	64
Nov 2022	149	153	53
Dec 2022	141	141	50
Jan 2023	171	177	74
Feb 2023	131	137	67
Mar 2023	152	153	66
Apr 2023	111	113	42
May 2023	148	149	53
Jun 2023	130	130	52
Jul 2023	76	77	36
Aug 2023	70	70	20
Sep 2023	81	82	33
Oct 2023	95	97	67
Nov 2023	80	80	38
Dec 2023	69	72	29
Jan 2024	97	100	61
Feb 2024	96	97	64
Mar 2024	103	104	69
Total	3272	3362	1288